placeholder image
WC Cushman All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Average clinician-measured blood pressures and cardiovascular outcomes in patients with type 2 diabetes mellitus and ischemic heart disease in the EXAMINE Trial
    Journal of the American Heart Association. 2018
  • Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome
    Clinical Cardiology. 2018
  • Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial
    JAMA internal medicine. 2017
  • Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial
    Diabetes, Obesity & Metabolism. 2017
  • Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin
    Hypertension (Dallas, Tex.. 2016
  • Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial
    Diabetes care. 2016
  • Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial: prevalence, incidence, and prognostic significance
    Hypertension (Dallas, Tex.. 2016
  • Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial
    Diabetes care. 2014
  • Alogliptin after acute coronary syndrome in patients with type 2 diabetes
    New England Journal of Medicine. 2013
  • Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex
    Hypertension (Dallas, Tex.. 2013
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients
    Kidney International. 2012
  • Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study
    Circulation: Cardiovascular Quality and Outcomes. 2012
  • EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome
    American Heart Journal. 2011
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes
    New England Journal of Medicine. 2011
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
    Lancet (London, England). 2010
  • Effects of combination lipid therapy in type 2 diabetes mellitus
    New England Journal of Medicine. 2010
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus
    New England Journal of Medicine. 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes
    New England Journal of Medicine. 2010
  • ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses
    Archives of Internal Medicine. 2009
  • Effects of intensive glucose lowering in type 2 diabetes
    New England Journal of Medicine. 2008
  • Effects of intensive glucose lowering in type 2 diabetes N Engl J Med
    2008
  • Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Hypertension (Dallas, Tex.. 2007
  • Contact
    full name
  • WC Cushman
  • W. C. Cushman
  • Quick Info
     
    Collaboration